30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Azita Saleki-Gerhardt

Track

Insider profile

Currently holds positions in Abbvie Inc and Entegris Inc

Performance

Overall performance
3.0
Performance over holding periods
3.0
30 days 90 days 120 days
Average return -4% 8.2% 15.1%
Success rate 26% 68% 82%
Transactions
35 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Executive Vice President - Operations Abbvie Inc Jan. 1, 2018 -
Independent Director Entegris Inc Aug. 14, 2017 -
Senior Vice President - Operations Abbvie Inc Jan. 2, 2013 - Jan. 1, 2018
Azita Saleki-Gerhardt's trades of Abbvie Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-08-14 2025-08-12
US Abbvie Inc (ABBV)
S Sale
65,816 +21.3%
416.55
US$4,910,504 		65,816 +21.3% 416.55 US$4,910,504
2025-08-12 2025-08-12
US Abbvie Inc (ABBV)
PrS Proposed sale
8,251
318.74
US$2,154,610 		8,251 318.74 US$2,154,610
2024-02-23 2024-02-21
US Abbvie Inc (ABBV)
S Sale
5,639 -39.0%
494.39
US$1,160,487 		5,639 -39.0% 494.39 US$1,160,487
2024-02-21 2024-02-21
US Abbvie Inc (ABBV)
PrS Proposed sale
52,870
173.72
US$9,184,487 		52,870 173.72 US$9,184,487
2023-03-02 2023-03-01
US Abbvie Inc (ABBV)
S Sale
780 -0.4%
153.39
US$119,644 		780 -0.4% 153.39 US$119,644
2023-03-02 2023-03-01
US Abbvie Inc (ABBV)
S Sale
9,220 -4.6%
153.05
US$1,411,121 		9,220 -4.6% 153.05 US$1,411,121
2023-03-02 2023-03-01
US Abbvie Inc (ABBV)
S Sale
26,990 -11.9%
155.00
US$4,183,450 		26,990 -11.9% 155.00 US$4,183,450
2023-02-21 2023-02-17
US Abbvie Inc (ABBV)
S Sale
10,754 -4.4%
150.05
US$1,613,638 		10,754 -4.4% 150.05 US$1,613,638
2023-02-21 2023-02-17
US Abbvie Inc (ABBV)
S Sale
14,246 -5.5%
149.13
US$2,124,506 		14,246 -5.5% 149.13 US$2,124,506
2021-05-26 2021-05-24
US Abbvie Inc (ABBV)
S Sale
9,057 -7.2%
116.70
US$1,056,996 		9,057 -7.2% 116.70 US$1,056,996
2021-05-26 2021-05-24
US Abbvie Inc (ABBV)
S Sale
77,863 -38.3%
116.24
US$9,051,036 		77,863 -38.3% 116.24 US$9,051,036
2020-11-12 2020-11-10
US Abbvie Inc (ABBV)
S Sale
17,426 -15.3%
98.00
US$1,707,748 		17,426 -15.3% 98.00 US$1,707,748
2020-11-06 2020-11-04
US Abbvie Inc (ABBV)
PlS Planned sale
4,800 -4.2%
93.61
US$449,328 		4,800 -4.2% 93.61 US$449,328
2019-03-06 2019-03-05
US Abbvie Inc (ABBV)
S Sale
15,797 -14.5%
79.03
US$1,248,480 		15,797 -14.5% 79.03 US$1,248,480
2018-03-02 2018-02-28
US Abbvie Inc (ABBV)
S Sale
1,337 -1.4%
117.77
US$157,458 		1,337 -1.4% 117.77 US$157,458
2017-09-12 2017-09-11
US Abbvie Inc (ABBV)
S Sale
2,338 -2.7%
85.06
US$198,870 		2,338 -2.7% 85.06 US$198,870
2017-09-12 2017-09-11
US Abbvie Inc (ABBV)
S Sale
1,030 -1.2%
85.04
US$87,591 		1,030 -1.2% 85.04 US$87,591
2017-09-12 2017-09-11
US Abbvie Inc (ABBV)
S Sale
132 -0.1%
85.03
US$11,224 		132 -0.1% 85.03 US$11,224
2017-09-12 2017-09-11
US Abbvie Inc (ABBV)
S Sale
3,600 -3.9%
85.00
US$305,982 		3,600 -3.9% 85.00 US$305,982
2017-09-12 2017-09-11
US Abbvie Inc (ABBV)
S Sale
1,200 -1.3%
84.99
US$101,988 		1,200 -1.3% 84.99 US$101,988
2016-03-02 2016-02-29
US Abbvie Inc (ABBV)
S Sale
1,776 -2.1%
55.38
US$98,350 		1,776 -2.1% 55.38 US$98,350
2015-03-03 2015-02-27
US Abbvie Inc (ABBV)
S Sale
2,112 -2.0%
60.47
US$127,706 		2,112 -2.0% 60.47 US$127,706
2014-03-04 2014-03-03
US Abbvie Inc (ABBV)
S Sale
100 -0.1%
50.26
US$5,026 		100 -0.1% 50.26 US$5,026
2014-03-04 2014-03-03
US Abbvie Inc (ABBV)
S Sale
200 -0.2%
50.26
US$10,053 		200 -0.2% 50.26 US$10,053
2014-03-04 2014-03-03
US Abbvie Inc (ABBV)
S Sale
100 -0.1%
50.26
US$5,026 		100 -0.1% 50.26 US$5,026
2014-03-04 2014-03-03
US Abbvie Inc (ABBV)
S Sale
100 -0.1%
50.25
US$5,025 		100 -0.1% 50.25 US$5,025
2014-03-04 2014-03-03
US Abbvie Inc (ABBV)
S Sale
581 -0.7%
50.25
US$29,195 		581 -0.7% 50.25 US$29,195
2014-03-04 2014-03-03
US Abbvie Inc (ABBV)
S Sale
1,200 -1.4%
50.25
US$60,295 		1,200 -1.4% 50.25 US$60,295
2014-03-04 2014-03-03
US Abbvie Inc (ABBV)
S Sale
162 -0.2%
50.24
US$8,139 		162 -0.2% 50.24 US$8,139
2014-02-07 2014-02-05
US Abbvie Inc (ABBV)
S Sale
387 -0.6%
47.84
US$18,512 		387 -0.6% 47.84 US$18,512
2014-02-07 2014-02-05
US Abbvie Inc (ABBV)
S Sale
300 -0.5%
47.85
US$14,354 		300 -0.5% 47.85 US$14,354
2013-09-18 2013-09-17
US Abbvie Inc (ABBV)
S Sale
1,789 -2.6%
46.48
US$83,153 		1,789 -2.6% 46.48 US$83,153
2013-09-18 2013-09-17
US Abbvie Inc (ABBV)
S Sale
3,695 -5.1%
46.00
US$169,970 		3,695 -5.1% 46.00 US$169,970
2013-09-18 2013-09-16
US Abbvie Inc (ABBV)
S Sale
4,989 -7.1%
45.50
US$227,000 		4,989 -7.1% 45.50 US$227,000
2013-08-20 2013-08-19
US Abbvie Inc (ABBV)
S Sale
1,270 -1.9%
43.01
US$54,623 		1,270 -1.9% 43.01 US$54,623
2013-08-13 2013-08-12
US Abbvie Inc (ABBV)
S Sale
5,006 -7.2%
45.01
US$225,307 		5,006 -7.2% 45.01 US$225,307
2013-08-13 2013-08-09
US Abbvie Inc (ABBV)
S Sale
3,845 -5.6%
44.78
US$172,176 		3,845 -5.6% 44.78 US$172,176
2013-03-12 2013-03-08
US Abbvie Inc (ABBV)
S Sale
496 -0.8%
37.50
US$18,600 		496 -0.8% 37.50 US$18,600